Bristol-Myers Squibb Company

Healthcare · Drug Manufacturers - General

62.90$ +2.2% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Bristol-Myers Squibb Company (BMY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 90,038 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BMY
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	14,685	14,977	16,272	17,114	17,578	27,057	25,022	27,448	30,435	28,138	25,575	26,172	29,486	31,008	31,076	32,970	35,897	38,592	33,749	31,748	33,707	33,551	34,986	129,944	118,481	109,314	96,820	95,159	92,603	90,038
Current Assets	7,528	7,736	8,782	9,267	9,824	12,349	10,060	11,997	14,801	12,283	10,302	10,348	14,697	13,958	13,273	15,318	9,521	18,916	14,608	10,415	13,704	14,854	17,716	29,354	30,192	33,262	27,273	31,770	29,780	29,390
Cash	1,681	1,456	2,244	2,720	3,182	5,500	2,367	2,549	3,680	3,050	2,018	1,801	7,976	7,683	5,033	5,776	1,656	3,586	5,571	2,385	4,237	5,421	6,911	12,346	14,546	13,979	9,123	11,464	10,346	10,209
Cash & Short-Term Investments	1,681	1,456	2,244	2,957	3,385	5,654	3,989	5,562	7,474	5,799	4,013	2,225	8,265	8,514	7,301	8,733	2,829	4,525	7,435	4,270	6,350	6,812	8,759	15,393	16,450	17,221	9,253	12,280	10,859	10,673
Receivables	2,651	2,973	3,190	3,272	3,662	3,949	2,968	3,660	4,373	3,378	3,247	4,240	3,644	3,164	3,480	3,743	3,083	3,360	3,390	4,299	5,543	6,300	5,747	7,685	10,554	12,516	13,937	15,264	14,424	14,525
Inventory	1,669	1,799	1,873	2,126	1,831	1,487	1,608	1,601	1,830	2,060	2,079	2,162	1,765	1,413	1,204	1,384	1,657	1,498	1,560	1,221	1,241	1,166	1,195	4,293	2,074	2,095	2,339	2,662	2,557	2,690
Property, Plant & Equipment	–	–	–	–	4,548	4,887	5,321	5,712	5,765	5,693	5,673	5,650	5,405	5,055	4,664	4,521	5,333	4,579	4,417	4,412	4,980	5,001	5,027	6,252	5,886	6,049	6,255	8,036	8,360	9,125
Goodwill	1,508	1,625	1,587	1,502	1,436	5,200	4,836	4,836	4,905	4,823	4,829	4,998	4,827	5,218	5,233	5,586	7,635	7,096	7,027	6,881	6,875	6,863	6,538	22,488	20,547	20,502	21,149	21,169	21,719	21,754
Intangible Assets	1,508	1,625	1,587	1,502	384	2,247	1,904	1,732	2,260	1,921	1,852	1,330	1,151	2,865	3,370	3,124	8,778	2,318	1,753	1,419	1,385	1,210	1,091	63,969	53,449	42,775	36,355	27,485	23,643	19,103
Total Liabilities	8,115	7,758	8,696	8,469	8,398	16,321	16,266	17,662	20,233	16,930	15,584	15,610	17,278	16,223	15,438	17,103	22,259	23,356	18,766	17,324	17,360	21,704	20,859	78,246	80,599	73,308	65,702	65,674	76,215	71,532
Current Liabilities	5,050	5,032	5,791	5,537	5,632	8,826	8,487	7,461	9,843	6,890	6,496	8,644	6,710	6,313	6,739	7,780	8,279	12,440	8,461	8,017	8,841	9,563	10,654	18,304	19,080	21,868	21,890	22,262	23,774	23,417
Short-Term Debt	513	543	482	432	162	174	1,379	232	1,883	231	187	1,891	154	231	117	115	826	359	590	139	992	987	1,703	3,479	2,504	5,117	4,400	3,281	2,227	2,463
Accounts Payable	1,064	1,017	1,380	1,657	1,702	1,587	1,551	1,893	2,127	1,579	1,239	1,442	1,535	1,711	1,983	2,603	2,202	2,559	2,487	1,565	1,664	2,248	1,892	2,445	2,713	2,949	3,040	3,259	3,602	3,575
Long-Term Debt	–	–	–	–	1,336	6,237	6,261	8,522	8,463	8,364	7,248	4,381	6,585	6,130	5,328	5,376	6,568	7,981	7,242	6,550	5,716	6,975	5,646	43,387	48,336	39,605	35,056	36,653	47,603	42,850
Shareholders' Equity	6,570	7,219	7,576	8,645	9,180	10,736	8,756	9,786	10,202	11,208	9,991	10,562	12,241	14,843	15,713	15,956	13,623	15,154	14,852	14,266	16,177	11,741	14,031	51,598	37,822	35,946	31,061	29,430	16,335	18,473
Retained Earnings	9,260	10,950	12,540	15,000	17,782	20,686	18,503	19,439	19,651	20,464	19,845	19,762	22,549	30,760	31,636	33,069	32,733	32,952	32,541	31,613	33,513	31,160	34,065	34,474	21,281	23,820	25,503	28,766	14,912	16,896
Shares Outstanding	2,036	2,042	2,031	2,027	1,997	1,965	2,016	1,950	1,976	1,983	1,963	1,980	2,001	1,978	1,727	1,717	1,688	1,662	1,670	1,679	1,680	1,652	1,637	1,712	2,258	2,245	2,146	2,078	2,027	2,041

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings